Essentials of Glycobiology Lecture 8 April 8, 2004 Hud Freeze Structure, biosynthesis and general biology of Glycophospholipid (GPI) Anchors.

Download Report

Transcript Essentials of Glycobiology Lecture 8 April 8, 2004 Hud Freeze Structure, biosynthesis and general biology of Glycophospholipid (GPI) Anchors.

Slide 1

Essentials of Glycobiology
Lecture 8
April 8, 2004
Hud Freeze

Structure, biosynthesis and
general biology of
Glycophospholipid (GPI) Anchors


Slide 2

Major
Glycan
Classes in
Animal
Cells

CHONDROITIN
SULFATE

HYALURONAN
P

GLYCOSAMINOGLYCANS

HEPARAN SULFATE
S

S

S

S

S

NS

NS

-O-Ser

Proteoglycan
N-LINKED CHAINS
Ac

O-LINKED
CHAIN

GLYCOPHOSPHOLIPID
ANCHOR

P

S

O
Ser/Thr

GLYCOSPHINGOLIPID

N
Asn

N
Asn

INOSITOL

Glycoprotein

Ac

Sialic Acids

INSIDE
O
Ser

Etn
P

NH 2

OUTSIDE

O-LINKED GlcNAc

S

S

Ser-O-

P

S


Slide 3

Basic Glycosylphosphatidylinositol (GPI) Anchor

Phospholipid


Slide 4

Lecture Overview

Historical Background
Defining the Core Structure
Biosynthesis & Transfer of GPI Anchors
The Signal for Addition of GPI Anchors
Occurrence and Variations in Nature
Postulated Biological Roles
Genetic Disorders
Perspectives & Future Directions


Slide 5

Discovery of GPI-Anchors.
 1963-First data suggests protein-lipid anchors: crude
bacterial phospholipase C releases alkaline phosphatase
from mammalian cells.
 mid-1970’s Hiro Ikezawa in Japan, and Martin Low in the
U.S. show that purified bacterial phosphatidylinositol
phospholipase C releases some enzymes, e.g.,alkaline
phosphatase, from cell surfaces. Propose Inositolcontaining phospholipid protein linkage
 Alan Williams in U.K. notes that antigen Thy-1 properties
of glycolipid and glycoprotein.
 However: No structural data!
GPI-anchors? Really?


Slide 6

Discovery of GPI-Anchors
 The C-terminus of Thy-1 glycoprotein found to have both
fatty acids and ethanolamine.
 In 1981, Tony Holder and George Cross groups showed
that soluble form of the variant surface glycoprotein
(sVSG) of African trypanosomes contains an immunocrossreactive carbohydrate (CRD) attached to its Cterminus via an amide linkage involving ethanolamine.
 Mervyn Turner’s group showed that trypanosomes
contain an enzyme which rapidly releases the membraneassociated VSG (mfVSG) upon cellular damage. mfVSG
becomes water soluble.
sVSG so rapid membrane form is only detected by
rapidly boiling trypanosomes in (SDS) prior to
electrophoresis.


Slide 7

Discovery of GPI-Anchors.
 1985: Hart & Englund groups at Johns Hopkins show
that the lipid-anchor on VSG is added within one minute
of the polypeptide’s synthesis in the endoplasmic
reticulum (ER). They postulate a pre-assembled
membrane anchor is attached en bloc.
 1985: Michael Ferguson and colleagues at Oxford publish
a tour de force structural analysis of the glycolipid
attached to the mfVSG of trypanosomes. These studies
structurally define the term ‘glycosylphosphatidylinositol’ (GPI).

THE LESSON: SHOW ME THE STRUCTURE!!!


Slide 8

Basic Glycosylphosphatidylinositol (GPI) Anchor

Phospholipid


Slide 9

Examples of GPI-Anchored Proteins
Cell surface hydrolases
alkaline phosphatase
acetylcholinesterase
5’ nucleotidase
Adhesion molecules
neural cell adhesion molecule
heparan sulfate proteoglycan

Protozoal antigens
trypanosome VSG
leishmanial protease
plasmodium antigens
Mammalian antigens
carcinoembryonic antigen
Thy-1

Others
scrapie prion protein
folate receptor
decay accelerating factor


Slide 10


Slide 11

Structure of the Basic GPI Anchor
GPI-Li nked Protei n

= Mannose (Man)
NH 2 = Gl ucosami ne
Etn

= Ethanolami ne

P

= Phosphate

Etn
P

PNH Defect
NH 2

Pig-A

INOSITOL
P
Cell Sur face
Membr ane


Slide 12

PLANTS ALSO MAKE GPI-ANCHORS

QuickTime™ and a TIFF (Uncompressed) decompressor are needed to see this pi cture.

Casper Vroemen,http://www.dpw.wau.nl/molbi/mediacenter/images/embryo11.jpg


Slide 13

Studying GPI Biosynthesis in vitro
thin layer
chromatography
F

30 °C
O

cell membranes
salts, buffers
radiolabeled
sugardonor

add solvents
spin
evaporate

O

F


Slide 14

Structural Analysis
of the GPI Anchor
Enzymatic and
chemical
cleavage sites
are useful in
identifying
GPI anchored
membrane proteins


Slide 15


Slide 16


Slide 17

Proposed
branched
pathway for
biosynthesis of
mammalian GPI
anchors


Slide 18

Examples of C-Terminal Sequences Signaling
the Addition of GPI-Anchors
Protein

GPI-Signal Sequence

Acetylcholinesterase (Torpedo)

NQFLPKLLNATAC DGELSSSGTSSSKGIIFYVLFSILYLIFY

Alkaline Phosphatase (placenta)

TACDLAPPAGTTD AAHPGRSVVPALLPLLAGTLLLLETATAP

Decay Accelerating Factor

HETTPNKGSGTTS GTTRLLSGHT CFT LTGLLGTLVTMGLLT

PARP (T. Brucei)

EPEPEPEPEPEPG AATLKSVALPFAIAAAALVAAF

Prion Protein (hamster)

QKESQAYYDGRRS SAVLFSSPPVILLISFLIFLMVG

Thy-1 (rat)
Variant Surface Glycoprotein (T . Brucei)

KTINVIRDKLVKC GGISLLVQNT SWLLLLLLSLSFLQATDFISI
ESNCKWENNACKD SSILVTKKFALTVVSAAFVALLF

Bold AA is site of GPI attachment Sequence to
right is cleaved by the transpeptidase
upon Anchor addition


Slide 19

Rules for C-Terminal Sequences Signaling
the Addition of GPI-Anchors
Residue to which anchor is attached (termed w
site) and residue two amino acids on carboxyl side
(w + 2 site) always have small side-chains
 w + 1 site can have large side-chains.

w + 2 site followed by 5 to 10 hydrophilic amino
acids,
Next, add fifteen to twenty hydrophobic amino
acids at or near the carboxy-terminus


Slide 20

GPI Anchor Functions
Dense packing of Proteins on Cell Surface
Increased Protein mobility on Cell Surface
Targeting of proteins to Apical Domains
Specific release from Cell Surface
Control of Exit from ER?
Developmental regulation of protein
expression?
Generation of Protein Complexity
Signal transduction?
Toxin Binding
Parasite Cell structure


Slide 21

Possible Role of the GPI-Anchor in ER Exit
Negative Signal: Retention mechanism is displaced by anchor

transport vesicles
-

-

Positive Signal: Anchor is recognized by packaging machinery

transport vesicles
+

+


Slide 22

UPS AND DOWNS OF GPI-LINKED PLACENTAL ALKALINE PHOSPHATASE

QuickTime™ and a TIFF (Uncompressed) decompressor are needed to see this picture.

Frances J. Sharom

www.chembio.uoguelph.ca/ sharom/


Slide 23

Sean Munro, Cell, 115, 377-388, Nov 2003


Slide 24

QuickTi me™ and a T IFF (Uncompressed) decompressor are needed to see this picture.


Slide 25

CHONDROITIN
SULFATE

HYALURONAN
P

GLYCOSAMINOGLYCANS

S

S

Ser-O-

HEPARAN SULFATE
Paroxysmal Nocturnal
Hemoglobinuria:
Somatic Loss of Glycophospholipid
Anchors in Hematopoietic
Stem Cells
N-LINKED CHAINS
S

S

S

S

S

NS

NS

Ac

O-LINKED
CHAIN

GLYCOPHOSPHOLIPID
ANCHOR

P

S

O
Ser/Thr

GLYCOSPHINGOLIPID

-O-Ser

N
Asn

N
Asn

NH 2
INOSITOL

Glycoprotein

Ac

OUTSIDE
Sialic Acids

INSIDE
O-LINKED GlcNAc

O
Ser

Etn
P

P

S


Slide 26

Taroh Kinoshita

QuickTime™ and a TIFF (Uncompressed) decompressor are needed to see this picture.


Slide 27

• The first step in biosynthesis of the GPI
anchor requires at least four genes
• One of them, PIG-A is an X-linked gene

Mutation in PNH
MUTATIONS IN
DOL-P-MAN SYN
AND USE

Biosynthesis
of GPI anchors


Slide 28

Paroxysmal Nocturnal Hemoglobinuria
An acquired clonal hematopoietic stem cell
disorder characterized by intravascular hemolytic
anemia. Abnormal blood cells lack GPI-anchored
proteins due to a mutation in the PIG-A gene.
Lack of GPI-anchored complement regulatory
proteins, such as decay-accelerating factor (DAF)
and CD59, results in complement-mediated
hemolysis and hemoglobinuria.
Factors that determine why mutant clones
expand have not been determined.


Slide 29

Paroxysmal Nocturnal Hemoglobinuria
Pre existing PNH clones have a conditional growth
advantage depending on some factor present in
the marrow environment of PNH patients.
However, cells with the PNH phenotype have been
found at a frequency of 22 per million in normal
individuals. These rare cells were collected by flow
sorting and had PIG-A mutations.
Thus, PIG-A gene mutations are not sufficient for
the development of clinically evident PNH.


Slide 30

NON-POLITICAL FLIP-FLOP: A GOOD THING

Quic kT ime™ and a T IFF (Unc ompres sed) dec ompres sor are needed to s ee this picture.


Slide 31

Dol

Quic kT ime™ and a T IFF (Unc ompres sed) dec ompres sor are needed to s ee this picture.


Slide 32

CDG-If


Slide 33

PTPATIENT WITH DPM1 DEFICIENCY
Decreased Dol-P-Man synthesis

PATIENT HAS MPDU1 DEFICIENCY
Inefficient use of Dol-P-Man and Dol-P-Glc

Both patients are blind with severe developmental delay
Pathology may result from impaired N-linked or GPI-anchor synthesis


Slide 34

FUTURE PERSPECTIVES

THE FUNCTION OF GPI-ANCHORS IS STILL UNRESOLVED

LIKE THE FUNCTIONS OF GLYCOYSLATION
MAYBE ALL THE THEORIES ARE CORRECT